Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

October 8, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Drug to treat African trypanosomiasis (sleeping sickness) disease discovered

Epilepsy is more than a tremor- World Epilepsy day 8th February.

THE BRAIN’S REWARD SYSTEM: NEUROBIOLOGY OF DRUG ADDICTION

Drug to treat African trypanosomiasis (sleeping sickness) disease discovered
  • BiotechToday
  • World

Drug to treat African trypanosomiasis (sleeping sickness) disease discovered

bioxone February 8, 2021February 7, 2021

Husna, Amity University Kolkata

African trypanosomiasis, also known as sleeping sickness is a disease fatal to both humans and animals. It is transmitted to humans and animals by the tsetse fly.

 A vaccine for protection from this disease hasn’t been discovered making its transmission control rely on eliminating the tsetse fly population. Neurotoxic insecticides and pesticides can be sprayed on insects and are very much effective for insect and pest control but they harm the environment and they also reduce populations of some beneficial insect pollinator species.

 Recently an international team of researchers has suggested an environment-friendly alternative, the drug Nitisinone (NTBC). An FDA approved drug that can eliminate tsetse flies by targeting an essential digestive pathway. The pathway is co-shared by all blood-feeding insects.  Using this drug has the additional benefit of killing other blood-sucking arthropods like mosquitoes and ticks. 

This drug is deemed to be ecologically friendly.  It has the potential of reducing the transmission of African trypanosomiasis (sleeping sickness) in sub-Saharan Africa. Unlike any insecticide, The drug posses execution capabilities for only blood-feeding insects and not sugar feeders such as pollinating insects.

Also read: Epilepsy is more than a tremor- World Epilepsy day 8th February.

SOURCE:  Sterkel M, Haines LR, Casas-Sánchez A, Owino Adung’a V, Vionette-Amaral RJ, Quek S, et al. (2021) Repurposing the orphan drug nitisinone to control the transmission of African trypanosomiasis. PLoS Biol 19(1): e3000796. Published: January 26, 2021 https://doi.org/10.1371/journal.pbio.3000796

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged african trypanosoma disease disease by mosquito disease vector environmentally friendly FDA fda approved fda drugs insecticide sprayer insecticides mosquitoes sleeping sickness trypanosoma african sleeping sickness tsetse fly

3 thoughts on “Drug to treat African trypanosomiasis (sleeping sickness) disease discovered”

  1. Pingback: THE BRAIN’S REWARD SYSTEM: NEUROBIOLOGY OF DRUG ADDICTION - BioXone
  2. Diwita says:
    February 9, 2021 at 7:21 am

    Illuminating content and beautifully written!!

    Reply
    1. Farah Noor says:
      February 14, 2021 at 1:26 pm

      Wow😍😍😍 so useful information and easy to remember!

      Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Biotechnopedia
  • DNA-Tales

THE BRAIN’S REWARD SYSTEM: NEUROBIOLOGY OF DRUG ADDICTION

bioxone February 8, 2021

Shinjini Bandopadhyay, Amity University Kolkata Addiction is defined as a chronic, relapsing disease of the brain. It is a biological process that alters the neurochemical pathways in the brain. Although addictions may be of varying types, the most frequently occurring and the most damaging ones include substance abuse (drugs, alcohol, tobacco). Substance abuse physically affects […]

REWARD SYSTEM

Related Post

  • BiotechToday
  • World

Polypharmacy & Drug-Drug Interactions

BioTech Today August 2, 2021August 1, 2021

Shayan Ahmed, Jamia Millia Islamia, New Delhi Polypharmacy: Polypharmacy refers to the usage of several medicines at the same time. It is the combination of drugs, and has become a frequent practice in modern medicine, particularly among the elderly and patients with complicated illnesses. When two or more drugs are taken at the same time, […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Linked read sequencing reveals the ecological resilience of a human gut microbial community during antibiotic treatment

bioxone December 14, 2020December 14, 2020

Souradip Mallick, National Institute of Technology, Rourkela The gastrointestinal metagenome is aggregation of all the genomes of gut microbiota. The gut flora is established after birth, by which time the intestinal epithelium and the intestinal mucosal barrier that it secretes developed its tolerance and also provides a barrier to pathogenic organisms. The relationship between gut flora and humans is not merely commensal but rather a mutualistic  relationship. […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • India

SKIN CANCER KILLING BANDAGE DEVELOPED BY IISc

bioxone October 9, 2020October 9, 2020

Rohit Bhattacharjee, Amity University Kolkata Skin cancer, the most common kind of cancer, is mainly caused due to excessive exposure to the UV rays from the sun. They are of two types:- melanoma ( develops from pigment-producing skin cells called melanocytes) and non-melanoma (developed from other skin cells). Though non-melanoma skin cancer is more widespread, […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy